FDA Inspection
Eli Lilly and CompanyEli Lilly and Company – FDA Inspection, Nov 26, 2024
Record Details
This FDA Inspection record concerns Eli Lilly and Company, with an inspection on November 26, 2024, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · 87bf71b2-484f-44dc-b7c9-4c74b4ebeb48
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1255082
- FDA center
- Human Drugs
- Project area
- Compliance: Medical Devices
FDA Citations
1- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Eli Lilly and Company
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 11, 2026 | Not classified | Atlanta District Office |
Other documents for Eli Lilly and Company
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.